OCA
BSX icon

OpenArc Corporate Advisory’s Boston Scientific BSX Stock Holding History

OpenArc Corporate Advisory’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Sell
29,374
-90,412
-75% -$4.91M 0.01% 311
2026
Q1 		$7.52M Sell
119,786
-20,317
-15% -$1.63M 0.11% 121
2025
Q4 		$13.4M Buy
+140,103
New +$13.7M 0.22% 67

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OpenArc Corporate Advisory's BSX Position: Q2 2026 in Review

OpenArc Corporate Advisory reduced its Boston Scientific (BSX) stake by 75% in Q2 2026, selling an estimated $4.91M and leaving 29,374 shares worth $1.25M. The position accounts for 0.01% of the portfolio, ranked #311.

OpenArc Corporate Advisory first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $13.4M in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • OpenArc Corporate Advisory held 29,374 shares of Boston Scientific worth $1.25M as of Q2 2026.
  • OpenArc Corporate Advisory sold 90,412 Boston Scientific shares in Q2 2026, an estimated $4.91M.
  • Boston Scientific made up 0.01% of OpenArc Corporate Advisory's portfolio in Q2 2026, its #311 holding.
  • OpenArc Corporate Advisory first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • OpenArc Corporate Advisory's Boston Scientific position peaked at $13.4M in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.